These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33403386)
1. Reversal of apolipoprotein E4-dependent or chemical-induced accumulation of APP degradation products by vitamin C-induced release of heparan sulfate from glypican-1. Cheng F; Fransson LÅ; Mani K Glycobiology; 2021 Aug; 31(7):800-811. PubMed ID: 33403386 [TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokines induce accumulation of glypican-1-derived heparan sulfate and the C-terminal fragment of β-cleaved APP in autophagosomes of dividing neuronal cells. Cheng F; Fransson LÅ; Mani K Glycobiology; 2020 Jul; 30(8):539-549. PubMed ID: 32039447 [TBL] [Abstract][Full Text] [Related]
3. Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation. Cheng F; Cappai R; Ciccotosto GD; Svensson G; Multhaup G; Fransson LÅ; Mani K J Biol Chem; 2011 Aug; 286(31):27559-72. PubMed ID: 21642435 [TBL] [Abstract][Full Text] [Related]
4. Rapid nuclear transit and impaired degradation of amyloid β and glypican-1-derived heparan sulfate in Tg2576 mouse fibroblasts. Cheng F; Fransson LÅ; Mani K Glycobiology; 2015 May; 25(5):548-56. PubMed ID: 25527428 [TBL] [Abstract][Full Text] [Related]
5. Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products. Cheng F; Ruscher K; Fransson LÅ; Mani K Glycobiology; 2013 Dec; 23(12):1510-9. PubMed ID: 24026238 [TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein (APP)/APP-like protein 2 (APLP2) expression is required to initiate endosome-nucleus-autophagosome trafficking of glypican-1-derived heparan sulfate. Cheng F; Cappai R; Lidfeldt J; Belting M; Fransson LÅ; Mani K J Biol Chem; 2014 Jul; 289(30):20871-8. PubMed ID: 24898256 [TBL] [Abstract][Full Text] [Related]
7. Suppression of glypican-1 autodegradation by NO-deprivation correlates with nuclear accumulation of amyloid beta in normal fibroblasts. Cheng F; Fransson LÅ; Mani K Glycoconj J; 2015 Dec; 32(9):675-84. PubMed ID: 26318599 [TBL] [Abstract][Full Text] [Related]
8. Constitutive and vitamin C-induced, NO-catalyzed release of heparan sulfate from recycling glypican-1 in late endosomes. Mani K; Cheng F; Fransson LA Glycobiology; 2006 Dec; 16(12):1251-61. PubMed ID: 16971378 [TBL] [Abstract][Full Text] [Related]
9. Cytochrome b561, copper, β-cleaved amyloid precursor protein and niemann-pick C1 protein are involved in ascorbate-induced release and membrane penetration of heparan sulfate from endosomal S-nitrosylated glypican-1. Cheng F; Fransson LÅ; Mani K Exp Cell Res; 2017 Nov; 360(2):171-179. PubMed ID: 28893506 [TBL] [Abstract][Full Text] [Related]
10. The cyanobacterial neurotoxin β-N-methylamino-l-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells. Cheng F; Fransson LÅ; Mani K Exp Cell Res; 2019 Jun; 379(2):172-181. PubMed ID: 30953622 [TBL] [Abstract][Full Text] [Related]
11. Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells. Cheng F; Fransson LÅ; Mani K Glycobiology; 2022 Mar; 32(4):333-342. PubMed ID: 34939110 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction. Cheng F; Bourseau-Guilmain E; Belting M; Fransson LÅ; Mani K Glycobiology; 2016 Jun; 26(6):623-34. PubMed ID: 26791445 [TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of Heparan Sulfate Containing Amyloid Precursor Protein Degradation Products. Mani K Methods Mol Biol; 2022; 2303():279-288. PubMed ID: 34626386 [TBL] [Abstract][Full Text] [Related]
14. Interplay between APP and glypican-1 processing and α-synuclein aggregation in undifferentiated and differentiated human neural progenitor cells. Cheng F; Fransson LÅ; Mani K Glycobiology; 2023 May; 33(4):325-341. PubMed ID: 36790131 [TBL] [Abstract][Full Text] [Related]
15. The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo. Cappai R; Cheng F; Ciccotosto GD; Needham BE; Masters CL; Multhaup G; Fransson LA; Mani K J Biol Chem; 2005 Apr; 280(14):13913-20. PubMed ID: 15677459 [TBL] [Abstract][Full Text] [Related]
16. Common traffic routes for imported spermine and endosomal glypican-1-derived heparan sulfate in fibroblasts. Cheng F; Fransson LÅ; Mani K Exp Cell Res; 2018 Mar; 364(2):133-142. PubMed ID: 29408503 [TBL] [Abstract][Full Text] [Related]
17. Interplay between glypican-1, amyloid-β and tau phosphorylation in human neural stem cells. Cheng F; Fransson LÅ; Mani K Neuroscience; 2024 Aug; 553():121-127. PubMed ID: 38992568 [TBL] [Abstract][Full Text] [Related]
18. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429 [TBL] [Abstract][Full Text] [Related]
19. Nucleolin is a nuclear target of heparan sulfate derived from glypican-1. Cheng F; Belting M; Fransson LÅ; Mani K Exp Cell Res; 2017 May; 354(1):31-39. PubMed ID: 28300561 [TBL] [Abstract][Full Text] [Related]
20. Vascular Heparan Sulfate and Amyloid-β in Alzheimer's Disease Patients. McMillan IO; Gearing M; Wang L Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]